Overview
Qiuhong Xiong practices in Taiyuan, China. Xiong is rated as a Distinguished expert by MediFind in the treatment of Beta-Propeller Protein-Associated Neurodegeneration. Their top areas of expertise are Beta-Propeller Protein-Associated Neurodegeneration, Small Patella Syndrome, Spondyloepiphyseal Dysplasia, and Spondyloepiphyseal Dysplasia Congenita.
Their clinical research consists of co-authoring 31 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Beta-Propeller Protein-Associated Neurodegeneration.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Beta-Propeller Protein-Associated Neurodegeneration
- Advanced
- Small Patella SyndromeXiong isAdvanced. Learn about Small Patella Syndrome.
- Spondyloepiphyseal Dysplasia
- Spondyloepiphyseal Dysplasia Congenita
- Experienced
- Acute Intermittent PorphyriaXiong isExperienced. Learn about Acute Intermittent Porphyria.
- Brachydactyly Mononen TypeXiong isExperienced. Learn about Brachydactyly Mononen Type.
- Dyskeratosis CongenitaXiong isExperienced. Learn about Dyskeratosis Congenita.
- Fabry DiseaseXiong isExperienced. Learn about Fabry Disease.
- LeukoplakiaXiong isExperienced. Learn about Leukoplakia.
- Mucopolysaccharidosis Type 1 (MPS I, Hurler Syndrome)